S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease

• Status: Recruiting
• Trial end date: 2021-12-31
• Target enrollment: 0
• Participant gender: All

Summary

With the Westernization of the diet and insufficient exercise, Taiwan's population of obesity, diabetes, and hyperlipidemia has increased in recent years, and the prevalence of the non-alcoholic fatty liver disease has gradually increased. Although weight loss, dietary adjustments, and certain drug treatments can delay the deterioration of the disease; however, weight loss and dietary adjustment are not easy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Taipei Medical University WanFang Hospital
• Collaborator: Sheng Pu Pharmaceutics Co., Ltd.

Criteria

Inclusion Criteria:

• Patients with fatty liver diagnosed by abdominal ultrasound or hepatic fibrometer within half a year's data

• Subjects with the non-alcoholic fatty liver disease

• The severity of fatty liver should be at least 3 points by taking an abdominal ultrasound

Exclusion Criteria:

• Female patients are pregnant or breastfeeding.

• Patients with viral hepatitis.

• Long-term drinkers.

• Those who use slimming products and vitamin E.